ENTA (STOCKS)
Enanta Pharmaceuticals, Inc
$13.440000
-0.060000 (-0.44%)
Prev close: $13.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jay R. Luly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $407.71M
- Employees
- 131
- P/E (TTM)
- -5.60
- P/B (TTM)
- 3.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $69.21M |
| Benefits Costs and Expenses | $131.11M |
| Costs And Expenses | $129.60M |
| Nonoperating Income/Loss | -$1.51M |
| Operating Expenses | $129.60M |
| Depreciation and Amortization | $4.93M |
| Research and Development | $91.32M |
| Other Operating Expenses | $33.34M |
| Operating Income/Loss | -$60.38M |
| Income/Loss From Continuing Operations After Tax | -$61.98M |
| Income/Loss From Continuing Operations Before Tax | -$61.89M |
| Income Tax Expense/Benefit | $92.00K |
| Net Income/Loss | -$61.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$61.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$61.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.60 |
| Diluted Earnings Per Share | -$2.60 |
| Basic Average Shares | 7,618,336 |
| Diluted Average Shares | 7,618,336 |
| Assets | $314.70M |
| Current Assets | $178.41M |
| Noncurrent Assets | $136.29M |
| Fixed Assets | $33.11M |
| Other Non-current Assets | $103.18M |
| Liabilities | $198.12M |
| Current Liabilities | $46.44M |
| Accounts Payable | $4.36M |
| Wages | $2.94M |
| Other Current Liabilities | $39.14M |
| Noncurrent Liabilities | $151.68M |
| Equity | $116.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $116.59M |
| Liabilities And Equity | $314.70M |
| Net Cash Flow From Operating Activities | -$7.84M |
| Net Cash Flow From Operating Activities, Continuing | -$7.84M |
| Net Cash Flow From Investing Activities | -$59.54M |
| Net Cash Flow From Investing Activities, Continuing | -$59.54M |
| Net Cash Flow From Financing Activities | $42.10M |
| Net Cash Flow From Financing Activities, Continuing | $42.10M |
| Net Cash Flow | -$25.29M |
| Net Cash Flow, Continuing | -$25.29M |
| Comprehensive Income/Loss | -$61.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$62.49M |
| Other Comprehensive Income/Loss | -$12.97M |
| Other Comprehensive Income/Loss Attributable To Parent | -$510.00K |